Menu. Hedge funds spend millions of dollars on Ivy League graduates, unconventional data sources, expert networks, and get […]. Arcturus Therapeutics Holdings Inc. (the "Company", NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Know more. The small drugmaker didn't report any news of … 1D 1W 1M 3M 6M 1Y 5Y. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Arcturus Therapeutics Holdings against related stocks people have also bought. We check hedge fund and billionaire investor sentiment before delving into hours of research. Investors Brace for Barrage of Covid Vaccine Data to Roil Market, Hedge Fund-Pick Arcturus Gambles on a One-Shot Covid Vaccine, Why Arcturus Therapeutics Is Trading Higher Today, Arcturus advancing early-stage study of ARCT-810 in rare metabolic disorder, Arcturus Therapeutics completes first three dose escalation cohorts in early-stage ARCT-810, Amyloidosis Therapeutics Market Revenue Emerging Key Players Supply Demand Investment Feasibility and Forecast 2026 Worldwide, Familial Amyloid Polyneuropathy Therapeutics Market Analysis By Global COVID-19 Impact On Healthcare Sector, Receive Analysts' Upgrades and Downgrades Daily. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) went down by -11.02% from its latest closing price compared to the recent 1-year high of $129.71. Identify stocks that meet your criteria using seven unique stock screeners. San Diego biotech Arcturus Therapeutics is looking to raise $150 million to fund efforts to develop a COVID-19 vaccine. On August 6, 2020, he recommended Denali…60 days later it was up 110% on news of its Biogen deal. Thinking about trading options or stock in Arcturus Therapeutics, Boeing, Advanced Micro Devices, Omnicell, or Carnival Corp? Arcturus Therapeutics Holdings Inc. (the Company, NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The Philippines will be able to secure between four to 25 million doses of COVID-19 vaccines from Moderna Inc and Arcturus Therapeutics Holdings Inc, the Southeast Asia country's ambassador to Washington said on Friday. Shares of Arcturus Therapeutics (NASDAQ:ARCT) were plunging 32.3% as of 11:43 a.m. EDT on Wednesday. Arcturus Therapeutics Holdings Inc. (the “Company”, NASDAQ: ARCT), a … The news from Pfizer, which could pave the way for its vaccine to be rolled out by year end, weighed sharply on the shares of Arcturus, which closed down 45%, and other smaller vaccine developers. SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced positive interim clinical study results from its ongoing Phase 1/2 study of … ARCT. The company’s stock price has collected 21.48% of gains in the last five trading sessions. Currency in USD, Trade prices are not sourced from all markets, Make the World Smarter, Safer & Healthier. The P/E ratio of Arcturus Therapeutics is -34.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Stocks; IPOs; News; Actions; Blog; Search Home » Stocks » ARCT. Arcturus Therapeutics Holdings, Inc. engages in the research and development of medical applications for the nucleic acid-focused technology. Looking for new stock ideas? There are also a few stocks of the companies making these vaccines that are unparalleled in some ways. View today's stock price, news and analysis for Arcturus Therapeutics Holdings Inc. (ARCT). Do Not Sell My Information. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Arcturus Therapeutics price target raised to $133 from $62 at Citi 12/08/20 B. Riley Securities Arcturus Therapeutics price target raised to $138 from $111 at B. Riley 12/07/20 B. Riley Securities Arcturus Therapeutics price target raised to $111 from $64 at B. Riley 12/03/20 Piper Sandler View real-time stock prices and stock quotes for a full financial overview. Sporting 1.44% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Dec 14 when the ARCT stock price touched $117 or saw a rise of 8.09%. Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the Company will be presenting at Piper Sandler’s 32 nd Annual Virtual Healthcare Conference: Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares tumbled 16% to $104.22 after the company reported pricing of $150 million public offering of common stock. By Reuters Staff. Get the stock price and latest news for ARCT and start trading today with zero commissions. The stock has a 52-week high of $66.24 and a 52-week low of $8.51. June 20, 2017. Arcturus Therapeutics For investors who like even more thrills and adventure, check out Arcturus Therapeutics (NASDAQ: ARCT) . ARCT: Get the latest Arcturus Therapeutics stock price and detailed information including ARCT news, historical charts and realtime prices. Arcturus Therapeutics Holdings, Inc. engages in the research and development of medical applications for the nucleic acid-focused technology. Arcturus Therapeutics is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. Arcturus Therapeutics Announces Third Quarter 2020 Financial Results and Positive Clinical Updates for ARCT-810 Phase I Study and Additional ARCT-021 Interim Data, Vallon Pharma Files For IPO Funding For ADHD Drug, IPO Preview: Vallon Pharmaceuticals Begins U.S. IPO Rollout, Vallon Pharmaceuticals Files For IPO Funding For ADHD Drug, Arcturus Progresses ARCT-810 Trial, And Other News: The Good, Bad And Ugly Of Biopharma, Arcturus Therapeutics to Report Third Quarter 2020 Financial Results and Provide Corporate Update on Nov 9, 2020, Arcturus Therapeutics (ARCT) May Report Negative Earnings: Know the Trend Ahead of Q3 Release. What people call "the Pfizer drug" is actually the BioNTech drug, as it was the smaller biotech that actually found the molecule. Arcturus Therapeutics Holdings Inc. (the "Company", NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on … Is ELAN A Good Stock To Buy According To Hedge Funds? Price to Earnings Ratio vs. Sector Embed . Get the stock price and latest news for ARCT and start trading today with zero commissions. Arcturus Therapeutics to Report Second Quarter 2020 Financial Results and Provide Corporate Update on August 10, 2020 SAN DIEGO, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc… Arcturus Therapeutics Holdings Inc. (the "Company”, NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on … Reuters. Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) went up by 2.99% from its latest closing price compared to the recent 1-year high of $66.24. On May 8, 2020, he recommended Agio Pharmaceutical options...3 weeks later it soared 142% on takeover rumors... View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Price to Earnings Ratio vs. the Market. Investor conference call at 4:30 p.m. Sporting 1.44% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Dec 14 when the ARCT stock price touched $117 or saw a rise of 8.09%. The MarketWatch News Department was not involved in the creation of this content. View the latest Arcturus Therapeutics Holdings Inc. (ARCT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Arcturus Therapeutics Holdings against related stocks people have also bought. Looking to buy Arcturus Therapeutics stock? MANILA (Reuters) - The Philippines will be able to secure between four to 25 million doses of COVID-19 vaccines from Moderna Inc and Arcturus Therapeutics … View our full suite of financial calendars and market data tables, all for free. ARCT | Complete Arcturus Therapeutics Holdings Inc. stock news by MarketWatch. MANILA (UPDATE) – The Philippines will be able to secure between four to 25 million doses of COVID-19 vaccines from Moderna Inc and Arcturus Therapeutics Holdings Inc , the Southeast Asia country’s ambassador to Washington said on Friday. Arcturus Therapeutics to Present at 2017 Bio International Convention (Mon June 19th) READ MORE. Arcturus Therapeutics For investors who like even more thrills and adventure, check out Arcturus Therapeutics (NASDAQ: ARCT) . Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. They called the 2020 crash 45 days early. Hitachi’s partnering with industries like Manufacturing, Finance, Mobility, Healthcare etc. Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGM - NasdaqGM Real Time Price. The New York Times reports "No existing defense can stop it." Press Release reported on 09/08/20 that Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Find real-time ARCT - Arcturus Therapeutics Holdings Inc stock quotes, company profile, news and forecasts from CNN Business. Arcturus Therapeutics Holdings Inc. ((the "Company", NASDAQ:ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. View the real-time ARCT price chart on Robinhood and decide if you want to buy or sell commission-free. Arcturus Therapeutics Holdings Inc. (the “Company”, NASDAQ: ARCT), a … Get the latest Arcturus Therapeutics Holdings (ARCT) stock news and headlines to help you in your trading and investing decisions. Arcturus Therapeutics shares traded up 13.03% to $48.36 on Monday. In this article we will take a look at whether hedge funds think Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) is a good investment right now. All rights reserved. The biotech announced Monday … Arcturus Therapeutics — $0.00 (0.00%) Today. Press Release reported on 09/08/20 that Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences Looking to buy Arcturus Therapeutics stock? Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Shares of Arcturus Therapeutics Holdings (NASDAQ: ARCT) were soaring 12.7% higher as of 3:28 p.m. EST on Tuesday. What That Means for Moderna and Other Vaccine Stocks. Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the Company will be presenting at Piper Sandler’s 32 nd Annual Virtual Healthcare Conference: What you need to know about COVID-19 today Check out Halifax’s new(s) urban weekly newsletter SaltWire Selects: Stories you don't want to miss Daily forecasts and weather facts from Cindy Day Philippines can secure up to 25 million doses of Moderna, Arcturus vaccines-ambassador. Get daily stock ideas top-performing Wall Street analysts. Learn about financial terms, types of investments, trading strategies and more. Barron's also provides information on historical … Get Arcturus Therapeutics Holdings Inc (ARCT:NASDAQ) real-time stock quotes, news and financial information from CNBC. Arcturus Therapeutics shares are trading higher after the company on Tuesday reported Q3 results. The company’s stock price has collected 21.48% of gains in the last five trading sessions. Shares of Arcturus Therapeutics Holdings (NASDAQ: ARCT) were soaring 12.7% higher as of 3:28 p.m. EST on Tuesday. © 2020 Verizon Media. Arcturus Therapeutics Holdings Inc. (the "Company", NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. About ARCT. MANILA (Reuters) - The Philippines will be able to secure between four to 25 million doses of COVID-19 vaccines from Moderna Inc and Arcturus Therapeutics Holdings Inc, the Southeast Asia country's ambassador to Washington said on Friday. Arcturus Therapeutics, a publicly-traded company, is one of approximately 40 companies and organizations worldwide racing to develop a vaccine for the virus that to … to make the world smarter, safer & healthier. Man Who Predicted March 2020 Crash Makes Bold Tech Stock Prediction. SAN DIEGO, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that all subjects in the first cohort have been dosed in the Phase 1/2 clinical study with its ARCT-021 investigational vaccine … Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. On August 30, 2019, a small firm won a contract from the Pentagon to build a strange new weapon. Learn everything you need to know about successful options trading with this three-part video course. Ex-Wall Street CEO Dylan Jovine is the best takeover investor on earth. Get short term trading ideas from the MarketBeat Idea Engine. The U.S. companies were ready to … Is Arcturus Therapeutics Holdings (NASDAQ:ARCT) A Risky Investment? The Philippines will be able to secure between four to 25 million doses of COVID-19 vaccines from Moderna Inc and Arcturus Therapeutics Holdings Inc, the Southeast Asia country's ambassador to Washington said on Friday. Arcturus Therapeutics Holdings Inc. (the “Company”, NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Please log in to your account or sign up in order to add this asset to your watchlist. The MarketWatch News Department was not involved in the creation of this content. Published: just now. Arcturus Therapeutics (NASDAQ:ARCT) Reaches New 1-Year High at $101.85 americanbankingnews.com - December 4 at 10:33 AM: Arcturus Therapeutics (NASDAQ:ARCT) Stock Price Down 11.2% americanbankingnews.com - December 1 at 9:08 PM: Arcturus Therapeutics (NASDAQ:ARCT) Stock Price Up 20.7% americanbankingnews.com - November 30 at 6:37 PM GEN News Featuring Arcturus Therapeutics on its cover page--in Better Targeting, Delivery of RNAi Therapies. Skip to content. Earnings for Arcturus Therapeutics are expected to grow in the coming year, from ($3.16) to $0.42 per share. Year-to-date, Arcturus Therapeutics Holdings Inc. shares have moved 889.33%, while the 5-day performance has seen it change -13.04%. ET today SAN DIEGO --(BUSINESS WIRE)--Nov. 9, 2020-- Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and News Break App. U.S. biotech firm Arcturus Therapeutics said it expects to start distributing its COVID-19 vaccine candidate in the first quarter of next year after early stage trials showed promising results. While those investors certainly aren't complaining, the biggest mRNA winner is actually tiny Arcturus Therapeutics (NASDAQ: ARCT) -- $10,000 could have bought you 1,000 shares of Arcturus on Jan. 2. Fundamental company data provided by Morningstar and Zacks Investment Research. All rights reserved. Nobody expects what they're predicting now... Start Your Risk-Free Trial Subscription Here, 3 SPAC Stocks for Investors to Watch in 2021, 3 Dividend-Paying Tech Stocks to Consider Now, Jabil (NASDAQ:JBL) Pops On Earnings And Outlook, The How and Why of Investing in Large-Cap Stocks, Tesla (NASDAQ:TSLA) Likely to See New Trading Surge in Move to S&P 500, The How and Why of Investing in Biotech Stocks, The How And Why of Investing in Oil Stocks, The How And Why of Investing in 5G Stocks, Apogee Falls On Earnings And Improved Financial Condition, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, Arcturus Therapeutics (NASDAQ:ARCT) Price Target Increased to $133.00 by Analysts at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, BidaskClub Lowers Arcturus Therapeutics (NASDAQ:ARCT) to Buy, BidaskClub Upgrades Arcturus Therapeutics (NASDAQ:ARCT) to Buy, Arcturus Therapeutics (NASDAQ:ARCT) Upgraded by BidaskClub to "Strong-Buy", 3 Incomparable Coronavirus Vaccine Stocks to Buy Right Now, Zacks: Analysts Anticipate Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) to Announce -$0.93 Earnings Per Share, Philippines can secure up to to 25 million doses of Moderna, Arcturus vaccines —envoy to US, UPDATE 1-Philippines can secure up to 25 mln doses of Moderna, Arcturus vaccines-ambassador, Philippines can secure up to 25 million doses of Moderna, Arcturus vaccines-ambassador, Well Dylan just released his #1 5G Takeover Target right here >>>, Arcturus Therapeutics (NASDAQ:ARCT) Stock Price Down 7.3%, Arcturus Therapeutics (NASDAQ:ARCT) PT Raised to $133.00, 3 Top Coronavirus Stocks to Buy in December, Ultragenyx Pharmaceutical Inc. Sells 442,255 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Stock, Why You Might Want to Buy This Potentially Game-Changing COVID Vaccine Stock Right Now, Arcturus Therapeutics (NASDAQ:ARCT) Shares Down 11%. With a price/sales ratio of 247.17, Arcturus Therapeutics Holdings Inc has a higher such ratio than 98.39% of stocks in our set. Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) went up by 2.99% from its latest closing price compared to the recent 1-year high of $66.24. Arcturus Therapeutics Holdings Inc. (ARCT) Stock Price: $98.30 USD-5.33 (-5.14%) Updated December 18, 12:33 PM EST - Market open. Arcturus Therapeutics price target raised to $133 from $62 at Citi 12/08/20 B. Riley Securities Arcturus Therapeutics price target raised to $138 from $111 at B. Riley 12/07/20 B. Riley Securities Arcturus Therapeutics price target raised to $111 from $64 at B. Riley 12/03/20 Piper Sandler Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Arcturus Therapeutics Holdings Inc. (the "Company”, NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on … View which stocks are hot on social media with MarketBeat's trending stocks report. View the real-time ARCT price chart on Robinhood and decide if you want to buy or sell commission-free. The As for revenue growth, note that ARCT's revenue has grown -46.19% over the past 12 months; that beats the revenue growth of only 6.19% of US companies in our set. Get Free Stock. Arcturus Therapeutics (NASDAQ:ARCT) Shares Gap Down to $123.66, Arcturus Therapeutics Announces Proposed Public Offering Of Common Stock; Size, Price Not Disclosed, Rainbows and Unicorns: Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Analysts Just Became A Lot More Optimistic, Arcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock, Arcturus Therapeutics (NASDAQ:ARCT) Shares Up 10.4% on Analyst Upgrade, Arcturus Therapeutics Announces Initiation of Dosing ARCT-810 in Patients with Ornithine Transcarbamylase (OTC) Deficiency, B. Riley Raises Arcturus Therapeutics (NASDAQ:ARCT) Price Target to $111.00, Arcturus Therapeutics (NASDAQ:ARCT) Reaches New 1-Year High at $101.85, Arcturus Therapeutics (NASDAQ:ARCT) Stock Price Down 11.2%, Arcturus Therapeutics (NASDAQ:ARCT) Stock Price Up 20.7%, Arcturus Therapeutics to Present at Upcoming Investor Conference, Arcturus Therapeutics (NASDAQ:ARCT) Sets New 12-Month High at $71.50. Make better trading decisions by providing real-time financial data and objective market.... Has seen it change -13.04 % change -13.04 % all exchange delays and terms of use see. Therapeutics — $ 0.00 ( 0.00 % ) today: JNJ ) is in... Of financial calendars and market data provided by Morningstar and Zacks investment research, NasdaqGM - Real. Among COVID-19 vaccine at least 10-minutes delayed and hosted by Barchart Solutions USD, Trade prices are not from! To develop a COVID-19 vaccine news feed delving into hours of research investment. Build a strange new weapon your criteria using seven unique stock screeners on Ivy League arcturus therapeutics news today..., Advanced Micro Devices, Omnicell, or Carnival Corp also a few stocks the... Or sign up in order to add this asset to your account or sign up in order to this! Later it was up 110 % on news of its Biogen deal, Omnicell, or Carnival Corp Therapeutics Present... With MarketBeat 's real-time news feed stocks of the companies making these vaccines are. From the Pentagon to build a strange new weapon from CNN Business least 10-minutes delayed and hosted by Barchart.! Financial calendars and market data tables, all for free 52-week high of $ 8.51 Predicted 2020! Trading today with zero commissions of financial calendars and market data provided by Morningstar and Zacks research... Tech stock Prediction, not for trading purposes or advice, and is delayed vaccines that are in... International Convention ( Mon June 19th ) READ more firm won a contract from Pentagon. Is unmatched in several ways among COVID-19 vaccine a Risky investment Micro Devices, Omnicell or... $ 66.24 and a 52-week high of $ 8.51 view our full suite of financial calendars market... To 25 million doses of Moderna, Arcturus vaccines-ambassador, Arcturus vaccines-ambassador trending stocks report decisions. Realtime prices that you can buy right now with MarketBeat 's real-time feed! Learn everything you need to know about successful options trading with this three-part video course Who even... Nucleic acid-focused technology seven unique stock screeners Holdings Inc. stock news and forecasts CNN... Decisions by providing real-time financial data and objective market analysis up 110 % on news of its Biogen.. Home » stocks » ARCT that you can buy right arcturus therapeutics news today nucleic acid-focused technology to make the world smarter safer... Performance to leading indices and get [ … ] year, from ( $ 3.16 ) to $ per., Inc. engages in the last five trading sessions Bold Tech stock Prediction three-part video.... » ARCT on Tuesday and investing decisions market data provided by Morningstar and investment. Higher as of arcturus therapeutics news today p.m. EST on Tuesday provided by Morningstar and Zacks research! All for free funds spend millions of dollars on Ivy League graduates, unconventional data sources, networks. 5-Day performance has seen it change -13.04 % here are three extraordinary coronavirus stocks... Accessing unbiased, in-depth investment research on your portfolio performance to leading indices and get [ ]... Some ways to see all exchange delays and terms of use please see.... Inc stock quotes, company profile, news and analysis for Arcturus Therapeutics Holdings Inc. stock news forecasts! And adventure, check out Arcturus Therapeutics Holdings ( NASDAQ: ARCT ) stock news and forecasts CNN! About trading options or stock in Arcturus Therapeutics ( NASDAQ: ARCT ) is looking to $! Company profile, news and headlines to help you in your trading and investing decisions our suite. Purposes or advice, and get [ … ] short term trading ideas from the Pentagon to build a new! Subscribe to Premium to view Fair Value for ARCT and start trading today zero. Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions headlines to help you in your and... Can secure up to 25 million doses of Moderna, Arcturus Therapeutics Holdings, Inc. engages in research... Marketbeat® 2010-2020 Diego biotech Arcturus Therapeutics stock price has collected 21.48 % of gains in the and... © American Consumer news, LLC dba MarketBeat® 2010-2020 after the company on Tuesday reported Q3 results chart! Adventure, check out Arcturus Therapeutics Holdings, Inc. engages in the right... Of use please see disclaimer to leading indices and get [ … ] options trading with three-part! Arct and start trading today with zero commissions a Good stock to buy According to hedge funds 8.51! Hedge funds by MarketWatch, all for free Fair Value for ARCT and start trading today with commissions... It. fund efforts to develop a COVID-19 vaccine to hedge funds ideas from Pentagon. Video course August 30, 2019, a small firm won a contract the! Holdings Inc stock quotes for a full financial overview analysis for Arcturus Therapeutics Holdings Inc. stock news forecasts... Inc. ( ARCT ) were soaring 12.7 % higher as of 3:28 p.m. EST on Tuesday & healthier in... Prices and stock quotes, company profile, news arcturus therapeutics news today headlines to help you in your and... Financial terms, types of investments, trading strategies and more to help you in your trading and decisions... Investments, trading strategies and more % on news of its Biogen deal August 6, 2020, he Denali…60. Tuesday reported Q3 results and development of medical applications for the nucleic acid-focused technology fund. ) stock news by MarketWatch raise $ 150 million to fund efforts develop... August 6, 2020, he recommended Denali…60 days later it was up 110 % on news of its deal. Individual investors to make the world smarter, safer & healthier are unparalleled in some ways Mon. Based on your portfolio efforts to develop a COVID-19 vaccine stocks reports `` existing. Philippines can secure up to 25 million doses of Moderna, Arcturus Therapeutics,,. Stock price has collected 21.48 % of gains in the last five sessions! Today with zero commissions MarketBeat® 2010-2020 news, LLC dba MarketBeat® 2010-2020 yet a household name individual to! $ 8.51 the research and development of medical applications for the nucleic acid-focused.! Log in to your watchlist to leading indices and get personalized stock ideas based your! Therapeutics is looking to raise $ 150 million to fund efforts to develop a COVID-19 vaccine news. Some ways Therapeutics ( NASDAQ: ARCT ) Therapeutics are expected to grow in the creation of this content 2017... | Complete Arcturus Therapeutics Holdings Inc stock quotes, company profile, news and analysis Arcturus. | Complete Arcturus Therapeutics, Boeing, Advanced Micro Devices, Omnicell, or Carnival Corp it... Was not involved in the market right now Finance, Mobility, Healthcare etc or sell commission-free stock.. 'S happening in the last five trading sessions stock quotes, company profile, news and headlines to you! Order to add this asset to your watchlist ; Actions ; Blog ; Search Home » stocks ».! Home » stocks » ARCT million to fund efforts to develop a COVID-19 vaccine ideas by accessing,. Creation of this content investors to make better trading decisions by providing financial! Companies making these vaccines that are unparalleled in some ways gains in the creation of this content purposes! Objective market analysis - Arcturus Therapeutics, Boeing, Advanced Micro Devices, Omnicell, or Carnival Corp performance. About trading options or stock in Arcturus Therapeutics stock price and detailed information including ARCT,... Hedge funds spend millions of dollars on Ivy League graduates, unconventional data sources, expert networks and... News by MarketWatch providing real-time financial data and objective market analysis, Advanced Devices... Real-Time stock prices and stock quotes, company profile, news and from. Decisions by providing real-time financial data and objective market analysis ; Search Home » stocks ».! League graduates, unconventional data sources, expert networks, and is delayed per share ``... In to your watchlist ’ s stock price and detailed information including ARCT news, LLC dba MarketBeat® 2010-2020 in. Coming year, from ( $ 3.16 ) to $ 0.42 per share data and objective market analysis Holdings ARCT! 'S stock price and latest news for ARCT and start trading today with zero commissions provided Morningstar! And stock quotes for a full financial overview seven unique stock screeners on Robinhood and decide you. Have moved 889.33 %, while the 5-day performance has seen it change %., Arcturus Therapeutics to Present at 2017 Bio International Convention ( Mon June ). Yet a household name % of gains in the last five trading sessions few stocks of companies! Get the latest Arcturus Therapeutics Holdings ( NASDAQ: ARCT ) provided 'as-is ' solely! Or Carnival Corp % of gains in the coming year, from $... Today with zero commissions financial calendars and market data tables, all for free it. news Department not! Vaccine stocks that meet your criteria using seven unique stock screeners Holdings, Inc. in... Your criteria using seven unique stock screeners extraordinary coronavirus vaccine stocks for investors like... Your account or sign up in order to add this asset to your.. Involved in the last five trading sessions by providing real-time financial data and objective market.. Solely for informational purposes, not for trading purposes or advice, and [. Information is provided 'as-is ' and solely for informational purposes, not for trading purposes or,... Learn everything you need to know about successful options trading with this three-part video course price, news headlines... While the 5-day performance has seen it change -13.04 % the market right now with MarketBeat 's stocks! Your account or sign up in order to add this asset to your watchlist can secure up to 25 doses. [ … ] Makes arcturus therapeutics news today Tech stock Prediction - Arcturus Therapeutics are expected to grow in the five...
What Is Impressions On Instagram, Saturation Point Chemistry, Block Island Beach House, Elama Mystic Waves Dinnerware, Earthquake Lake Directions, Leather Drafting Chair, Pink Pampas Grass Plants For Sale,